TuesdayJul 26, 2022 4:20 am

420 with CNW — President Biden Reaffirms Pledge to Fulfill Cannabis Campaign Promises

A few months after President Joseph Biden assumed office, his administration passed a major infrastructure bill that, among other things, provided billions of dollars for the development of a nationwide network of public electric vehicle chargers, fulfilling a promise he had made while on the campaign trail. However, the administration has been slow to pass the cannabis reforms President Biden had promised while campaigning, with Biden failing to make a definitive public statement about marijuana policy in the year and a half since he entered the Oval Office. After more than a year of silence on cannabis reforms, the president…

Continue Reading

MondayJul 25, 2022 4:20 pm

420 with CNW — Malta, The Netherlands, Luxembourg and Germany Hold Joint Meeting on Cannabis Legalization

Officials from several European countries recently met to discuss the factors involved in legalizing adult-use cannabis amid a wave of cannabis reform across the region. The historic meeting is expected to be the first of several multilateral discussions and could be expanded to include other countries. The joint meeting involved representatives from The Netherlands, Malta, Germany and Luxembourg. Advocates have lauded the meeting, stating that it is critical to cannabis reform in Europe by allowing member states to coordinate their marijuana regulations and dealing with any pushback from the United Nations (UN). As it stands, the UN currently bans member…

Continue Reading

MondayJul 25, 2022 12:00 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Notice of Allowance of 26th Worldwide Patent

Lexaria, a global innovator in drug delivery technology, has developed the patented DehydraTECH(TM) technology which has been the subject of several issued patents Recently, Lexaria reported it had been notified of the allowance of its 26th worldwide patent with a new patent to be granted in Japan The patent is the fourth to be granted in Japan and the first patent issued from Lexaria’s seventh patent family Lexaria also submitted a briefing book to the FDA to facilitate its upcoming pre-Investigational New Drug (“IND”) meeting with the agency “We are extremely pleased to have received our first patent protecting our…

Continue Reading

MondayJul 25, 2022 4:20 am

420 with CNW — Report Says Nearly 300 Jobs Are Created Daily in Cannabis Industry

The marijuana industry has grown significantly these last few years. A good way to determine just how rapidly it has grown is to look at how many employment opportunities the industry has created thus far. A new report by Leafly reported that roughly 280 new marijuana jobs are created every day. Cumulatively, this added up to an estimated 428,000 jobs by January 2022, making this particular industry one of the fastest-growing employers in the United States. This growth is particularly impressive if someone considers that it has been less than a decade since the states of Washington and Colorado began…

Continue Reading

FridayJul 22, 2022 4:20 pm

420 with CNW — Consumption Lounges Could Change Trajectory of Marijuana Industry

Nearly 20 states have now legalized recreational cannabis use. In these states, consumers aged 21 and older are allowed to purchase and consume cannabis for recreational purposes. However, most of these states have outlawed the public consumption of adult-use marijuana, meaning people have to consume their cannabis in private residences. Consequently, tourists face a unique challenge when it comes to recreational weed. While they are allowed to purchase cannabis in states with legal markets, they are rarely provided with a location to consume this cannabis, essentially making it impossible for them to consume cannabis unless they know a locale. Cannabis…

Continue Reading

FridayJul 22, 2022 4:20 am

420 with CNW — NIDA Boss Says Decriminalization Can Help Address Drug Addiction Problem

For the past couple of decades, America’s solution to the drug crisis has been criminalization. Most pundits agree that this approach has failed spectacularly, ruining millions of lives and indirectly channeling billions of dollars to the criminal enterprises behind the drug trade. Millions of Americans who would have benefited from medical treatment were branded as criminals and forced to spend years of their lives in prison. The result is a country that largely views drug addiction as a criminal rather than public health issue. According to a top federal health official, the United States will have to overhaul its approach…

Continue Reading

ThursdayJul 21, 2022 4:20 pm

420 with CNW — Study Finds That Safe Drug-Consumption Sites in NYC Reduce Overdose Risks

Safe drug-consumption sites, or locations where individuals with substance misuse disorders can consume illicit drugs under medical supervision, have been a controversial idea since they were first introduced. These sites have been designed to prevent drug overdoses by ensuring that people who use illicit drugs are in a safe environment when they use drugs and can receive the treatment they need. Unsurprisingly, the idea has faced plenty of political and legal challenges since federal law bans the use of most illicit drugs. Despite these challenges, research shows that safe consumption sites are effective at reducing the risk of overdosing. More…

Continue Reading

ThursdayJul 21, 2022 4:20 am

420 with CNW — Revised Lawsuit Wants DOJ to Explain Gun Ban for Medical Marijuana Users

Dozens of states may now allow medical and recreational cannabis, but continued federal prohibition has been a major thorn in the state-legal cannabis industry’s side. Marijuana’s federal classification as a Schedule I drug has made it nigh impossible for cannabis businesses to access financial services and significantly hindered investment in the industry. Furthermore, federal prohibition has led to plenty of cannabis consumers being penalized for engaging in acts, such as purchasing and consuming cannabis, that are legal in their state. A recent lawsuit seeks to understand the rationale behind one such penalty: preventing medical marijuana users from purchasing guns. After…

Continue Reading

WednesdayJul 20, 2022 4:20 pm

420 with CNW — Clinton Calls CBD Trial’s Results Encouraging for Pain Treatment

A recent press release by Orcosa highlights a statement made by former U.S. President Bill Clinton to the effect that the results of a clinical trial by NYU Langone, which tested the effectiveness of CBD in managing pain, were very encouraging. Clinton, who has in the past revealed that he used cannabis in his youth, has been keenly following the progression of these CBD trials. Orcosa is a life sciences company that is focused on modernizing the way drugs are taken through the use of its next-generation drug-delivery technology. The company supplied the CBD products used in the trial, which…

Continue Reading

WednesdayJul 20, 2022 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Pending Start of Human Nicotine Study, NIC-H22-1, Leveraging Fast-Growing Global Nicotine Pouches Market

Lexaria Bioscience Corp. expects the upcoming human nicotine study to produce evidence that its patented DehydraTECH(TM) technology can enhance oral-tissue absorption with reduced negative experiences Data collected from animal study NIC-A21-1 showed that DehydraTECH enhanced oral nicotine pouches delivered peak nicotine levels in the bloodstream of animals 10x to 20x faster than the control The global nicotine pouches market was valued at $2.33 billion in 2020 and is expected to reach $21.84 billion by 2027, being one of the fastest growing segments in the nicotine industry Lexaria's pipeline addresses serious unmet patient or consumer needs with greater market potential, addressing…

Continue Reading

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000